Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

Ventus progressing well in phase III

Jan. 13, 1997

Bio-Technology General's OxSODrol tested for safety and efficacy

Jan. 13, 1997

French investigators announce success of gene therapy for CF

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

RPR seeks FDA approval for Nasacort-HFA

Jan. 10, 1997

SciClone cystic fibrosis drug cleared for clinical testing

Jan. 10, 1997

Generic terfenadine approved for U.S. marketing

Jan. 10, 1997

Merck Frosst discloses leukotriene biosynthesis inhibitors

Jan. 10, 1997

New IL-4 antagonist from Hoechst

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...